Photodynamic therapy of neoplastic disease

Drugs of Today

Volumn 32, Issue 5, 1996, Pages 385-396

  Kessel, David ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PHOTOFRIN; PHOTOSENSITIZING AGENT;

CANCER; HEAD AND NECK CANCER; HUMAN; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; REVIEW;

EID: 0029809670     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. Henderson, B.W., Dougherty, T.J. How does photodynamic therapy work. Photochem Photobiol 1992, 55: 145-57.
2. Moan, J., Berg, K. Photochemotherapy of cancer: Experimental research. Photochem Photobiol 1992, 55: 931-48.
3. Profio, A.E., Doiron, D.R., Balchum, O.J. et al. Fluorescence bronchoscopy for localization of carcinoma in situ. Med Phys 1983, 10: 35-9.
4. Gomer, C.J., Rucker, N., Ferrario, A. et al. Expression of potentially lethal damage in Chinese hamster cells exposed to hematoporphyrin derivative photodynamic therapy. Cancer Res 1986, 46: 3348-52.
5. Abulafi, A.M., Williams, N.S. Photodynamic therapy for cancer: Still awaiting rigorous evaluation. Brit Med J 1992, 304: 589-90.
6. Van Hillegersberg, H., Kort, W.H., Wilson, J.H.P. Current status of photodynamic therapy in oncology. Drugs 1994, 48: 510-27.
7. Danis, R.P., Yang, Y., Massicotte, S.J. et al. Preretinal and optic nerve head neovascularization induced by photodynamic venous thrombosis in domestic pigs. Arch Ophthalmol 1993, 111: 539-43.
8. Dougherty, T.J., Henderson, B.W., Schwartz, S., Winkelman, J.W., Lipson, R.L. Historical perspective. In: Photodynamic Therapy. Henderson, B.W., Dougherty, T.J. (Eds.). Marcel Dekker: New York 1992, 11-5.
9. Dougherty, T.J., Kaufman, J.E., Goldfarb, A. et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978, 38: 2628-35.
10. Dougherty, T.J. Studies on the structure of porphyrins contained in Photofrin II. Photochem Photobiol 1987, 46: 569-73.
11. 4. Cancer Res 1987, 47: 4642-5.
12. 14C]-hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 1979, 39: 146-51.
13. Profio, A.E., Doiron, D.R. Dosimetry considerations in phototherapy. Med Phys 1981, 8: 190-6.
14. Van Gemert, J.C., Berenbaum, M.C., Gijsbers, G.H.M. Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative. Brit J Cancer 1985, 52: 43-9.
15. Evrard, S., Aprahamian, M., Marescaux, J. Intra-abdominal photodynamic therapy: From theory to feasibility. Brit J Surg 1993, 80: 298-303.
16. Oseroff, A. Photodynamic therapy. In: Clinical Photomedicine. Lim, H.W., Soter, N.A. (Eds.). Marcel Dekker: New York 1993, 387-402.
17. Pass, H.I. Photodynamic therapy in oncology: Mechanisms and clinical uses. J Natl Cancer Inst 1993, 85: 443-56.
18. Kessel, D. Milestones in Photodynamic Therapy. SPIE: Bellingham, Washington 1993.
19. Bonnett, R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev 1995, 24: 19-33.
20. Kessel, D. Transport and binding of hematoporphyrin derivative and related porphyrins by murine leukemia L1210 cells. Cancer Res 1981, 41: 1318-21.
21. Berenbaum, M.C., Bonnet, R., Scourides, P.A. In vivo biological activity of the components of haematoporphyrin derivative. Brit J Cancer 1982, 45: 571-81.
22. Pandey, R.K., Dougherty, T.J. Synthesis and photosensitizing activity of a diporphyrin ether. Photochem Photobiol 1988, 47: 769-77.
23. Allen, R., Kessel, D., Tharratt, R.S., Volz, W. Photodynamic therapy of superficial malignancies with NPe6 in man. In: Photodynamic Therapy and Biomedical Lasers. Spinelli, P., Dal-Fante, M., Marchese, R. (Eds.). Elsevier Science: New York 1992, 441-5.
24. Morgan, A.R, Garbo, G.M., Keck, R.W. et al. Tin (IV) etiopurpurin dichloride: An alternative to DHE? Proc SPIE 1987, 847: 172-9.
25. Selman, S.H., Keck, R.W. The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride: A pilot study. J Urol 1994, 152: 2129-32.
26. Bonnet, R., White, R.D., Winfield, U.J. et al. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem J 1989, 261: 277-80.
27. Van Geel, I.P.J., Oppelaar, H., Oussoren, Y.G., et al. Photosensitizing efficacy of mTHPC compared to Photofrin-PDT in the RIF1 mouse tumour and normal skin. Int J Cancer 1995, 60: 388-94.
28. Barr, H. Tralau, C.J., MacRobert, A.J. et al. Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation. Brit J Cancer 1987, 56: 111-8.
29. Bown, S.G., Tralau, C.J., Coleridge-Smith, P.D. et al. Photodynamic therapy with porphyrin and phthalocyanine sensitisation in normal rat liver. Brit J Cancer 1986, 54: 43-52.
30. Loh, C.S., Bedwell, J., MacRobert, A.J. et al. Photodynamic therapy of normal rat stomach: A comparative study between di-sulfonated aluminium phthalocyanine and 5-aminolaevulinic acid. Brit J Cancer 1992, 66: 452-62.
31. Richter, A., Kelley, B., Chow, J. et al. Preliminary studies on a more effective phototoxic agent than hematoporphyrin. J Natl Cancer Inst 1987, 79: 1327-32.
32. Young, S.W., Woodburn, K.W., Wright, M. et al. Lutecium texaphyrin (PCI-0123): A near-infrared, water-soluble photosensitizer. Photochem Photobiol 1996, 63: 892-7.
33. Young, S.W., Sidhu, M.K., Qing, F. et al. Preclinical evaluation of gadolinium (III) texaphyrin complex. Invest Radiol 1994, 29: 330-8.
34. Kennedy, J.C., Pottier, R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B Biol 1992, 14: 275-92.
35. Fromm, D., Webber, J., Kessel, D. Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer. Arch Surg 1996, 131: 667-9.
36. Wilson, J.H.P., Van Hillegersberg, R., Van Den Berg, J.W.O. et al. Photodynamic therapy for gastrointestinal tumors. Scand J Gastroenterol 1991, 188 (Suppl. 26): 20-5.
37. Moan, J. Effect of bleaching of porphyrin sensitizers during photodynamic therapy. Cancer Lett 1986, 33: 45-53.
38. Potter, W.R., Mang, T.S., Dougherty, T.J. The theory of photodynamic therapy dosimetry: Consequences of photodestruction of sensitizer. Photochem Photobiol 1987, 46: 97-101.
39. Levy, J. Photosensitizers in photodynamic therapy. Sem Oncol 1994, 21 (Suppl. 15): 410.
40. Jori, G., Beltramini, M., Reddi, E. et al. Evidence for a major role of plasma lipoprotein as hematoporphyrin carriers in vivo. Cancer Lett 1984, 24: 291-7.
41. Kessel, D. Porphyrin-lipoprotein association as a factor in porphyrin localization. Cancer Lett 1986, 33: 183-8.
42. Reyftmann, J.P., Morliere, P., Goldstein, S. et al. Interactions of human serum low density lipoproteins with porphyrins: A spectroscopic and photochemical study. Photochem Photobiol 1984, 40: 721-9.
43. Kessel, D., Whitcomb, K.L., Schulz, V. Lipoprotein-mediated distribution of N-aspartyl chlorin e6 in the mouse. Photochem Photobiol 1992, 56: 51-6.
44. 2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy resistant mouse tumor cells. Cancer Res 1995, 55: 1820-3.
45. Dougherty, T.J., Grindey, G.B., Fiel, R. et al. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 1976, 55: 115-21.
46. Cheli, R., Addis, F., Mortellaro, C.M. et al. Photodynamic therapy of spontaneous animal tumors using the active component of hematoporphyrin derivative (DHE) as photosensitizing drug: Clinical results. Cancer Lett 1987, 38: 101-5.
47. Dougherty, T.J., Thoma, R.E., Boyle, D.G. et al. Interstitial photoradiation therapy for primary solid tumors in pet cats and dogs. Cancer Res 1981, 41: 401-4.
48. Chapman, M.J. Comparative analysis of mammalian plasma lipoproteins. Meth Enzymol 1986, 128: 70-143.
49. Korbelik, M., Krosl, G., Olive, P.L. et al. Distribution of Photofrin between tumour cells and tumour associated macrophages. Brit J Cancer 1991, 64: 508-12.
50. Foster, T.H., Gao, L. Dosimetry in photodynamic therapy: Oxygen and the critical importance of capillary density. Radiat Res 1992, 130: 379-83.
51. Henderson, B.W., Dougherty, T.J., Malone, P.B. Studies on the mechanism of tumor destruction by photoradiation therapy. In: Porphyrin Localization and Treatment of Tumors. Doiron, D., Gomer, C.J. (Eds.). Alan R. Liss: New York 1984, 601-12.
52. Fingar, V.H., Wieman, T.J., Wiehle, S.A. et al. The role of microvascular damage in photodynamic therapy: The effect of treatment on vessel constriction, permeability and leukocyte adhesion. Cancer Res 1992, 52: 4914-21.
53. Henderson, B.W., Waldow, S.M., Mang, T.S. et al. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 1985, 45: 572-6.
54. Selman, S.H., Kreimer-Birnbaum, M., Goldblatt, P.J. et al. Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res 1984, 44: 1924-7.
55. Gibson, S.L., Foster, T.H., Feins, R.H. et al. Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Brit J Cancer 1994, 69: 473-81.
56. Henderson, B.W., Finger, V.H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 1987, 47: 3110-4.
57. Star, W.M., Marijnissen, H.P.A., Van den Berg-Blok, A.E. et. al. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res 1986, 46: 2532-40,
58. Henderson, B.W., Fingar, V.H. Relationship of tumor hypoxia and response to photodynamic treatment of a murine tumor model. Photochemistry 1989, 49: 299-3804.
59. Foster, T.H., Murant, R.S., Bryant, R.G. et al. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res 1991, 126: 296-303.
60. McMahon, K.S., Wieman, T.J., Moore, P.H. et al. Effects of photodynamic therapy using mono-1-aspartyl chlorin e6 on vessel constriction, vessel leakage and tumor response. Cancer Res 1994, 54: 5374-9.
61. Fingar, V.H., Wieman, T.J., Park, Y.J. et al. Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy. J Surg Res 1992, 54: 524-8.
62. Moan, J., Sommer, S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res 1985, 46: 1608-10.
63. Wieman, T.J., Mang, T.S., Fingar, V.H. et al. Effect of photodynamic therapy on blood flow in normal and tumor vessels. Surgery 1988, 104: 512-7.
64. Bremner, J.C.M., Bradley, J.K., Stratford, I. et al. Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy. Brit J Cancer 1994, 69: 1083-7.
65. 2H NMR spectroscopy. NMR Biomed 1990, 3: 64-70.
66. Van Geel, I.P.J., Oppelaar, H., Oussoren, Y.G. et al. Changes in perfusion of mouse tumours after photodynamic therapy. Int J Cancer 1994, 56: 224-8.
67. Dubbelman, T.M.A.R, DeGoeij, A.F.P.M., Van Steveninck, J. Protoporphyrin-induced photodynamic effects on transport processes across the membrane of human erythrocytes. Biochem Biophys Acta 1980, 595: 133-9.
68. Girotti, A.W. Photodynamic action of protoporphyrin IX on human erythrocytes: Crosslinking of membrane proteins. Biochem Biophys Res Commun 1967, 72: 1367-74.
69. Hilf, R., Smail, D.B., Murant, R.S. et al. Hematoporphyrin derivative-induced photosensitivity of mitochondrial succinate dehydrogenase and selected cytosolic enzymes of R3230AC mammary adenocarcinomas of rats. Cancer Res 1984, 44: 1483-8.
70. Agarwal, M.L., Clay, M.E., Harvey, E.J. et al. Photodynamic therapy induces rapid cell death by apoptosis in L518Y mouse lymphoma cells. Cancer Res 1991, 51: 5993-6.
71. He, X.Y., Sikes, R., Thomsen, S. et al. Photodynamic therapy with Photofrin II induces programmed cell death in carcinoma cell lines. Photochem Photobiol 1994, 59: 468-73.
72. Zaidi, S.I.A., Oleinick, N.L., Zaim, M.T. et al. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: Electron microscopic, histopathologic and biochemical evidence. Photochem Photobiol 1993, 58: 771-6.
73. Hickman, J.A., Potten, C.S., Merritt, A.J. et al. Apoptosis and cancer chemotherapy. Phil Trans R Soc Lond B 1994, 345: 319-25.
74. Dive, C., Hickman, J.A. Drug-target interactions: Only the first step in the commitment to a programmed cell death? Brit J Cancer 1991, 64: 192-6.
75. Tochner, Z., Mitchell, J.B., Harrington, F.S. et al. Treatment of murine intraperitoneal ovarian ascitic tumor with hematoporphyrin derivative and laser light. Cancer Res 1985, 46: 2983-7.
76. Ferrario, A., Gomer, C.J. Systemic toxicity in mice induced by localized porphyrin photodynamic therapy. Cancer Res 1990, 50: 539-43.
77. Dougherty, T.J., Laurence, G., Kaufman, J.H. et al. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 1979, 62: 231-7.
78. Cortese, D.A., Kinsey, J.H. Endoscopic management of lung cancer with hematoporphyrin derivative phototherapy. Mayo Clinic Proc 1982, 57: 543-7.
79. Hayata, Y., Kato, H., Konaka, C. et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 1982, 81: 269-76.
80. Benson, R.C. Jr, Kinsey, J.H., Cortese, D.A. et al. Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy. J Urol 1983, 130: 1090-5.
81. Nseyo, U.O., Dougherty, T.J., Boyle, D.G. et al. Some factors modulating the effect of photodynamic therapy of the bladder in a canine bladder model. Urology 1988, 32: 41-5.
82. Prout, G.R., Lin, C.W., Benson, R. et al. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. New Engl J Med 1987, 317: 1251-5.
83. Hudson, E.J., Stringer, M.R., Cairnduff, F. et al. The optical properties of skin tumors measured during superficial photodynamic therapy. Lasers Med Sci 1994, 9: 99-103.
84. Wilson, B.C., Patterson, M.S. The physics of photodynamic therapy. Phys Med Biol 1986, 31: 3276-360.
85. Fenning, M.C., Brown, D.Q., Chapman, J.D. Photodosimetry of interstitial light delivery to solid tumors. Med Phys 1994, 21: 1149-56.
86. Kaye, A.H., Morstyn, G., Apuzzo, M.L.J. Photoradiation therapy and its potential in the management of neurological tumors. J Neurosurg 1988, 69: 1-14.
87. Muller, P.J., Wilson, B.C. Photodynamic therapy of malignant primary brain tumors. Clinical effects, post-operative ICP, and light penetration of the brain. Photochem Photobiol 1987, 46: 929-35.
88. Feyh, J., Goetz, A., Muller, W. et al. Photodynamic therapy in head and neck surgery. J Photochem Photobiol B Biol 1990, 7: 353-8.
89. Gluckman, J.L., Waner, M., Shumrick, K. et al. Photodynamic therapy. A viable alternative to conventional therapy for early lesions of the upper aerodigestive tract? Arch Otolaryngol Head Neck Surg 1986, 112: 949-52.
90. Harris, D.M., Hill, J.H., Werkhaven, J.A. et al. Porphyrin fluorescence and photosensitization in head and neck cancer. Arch Otolaryngol Head Neck Surg 1986, 112: 1194-9.
91. Tse, D., Dutton, J.J., Weingeist, T.A. et al. Hematoporphyrin radiation therapy for intraocular and orbital malignant melanoma. Arch Ophthalmol 1984, 192: 833-8.
92. Lobraico, R.V., Waldow, S.M., Harris, D.M. et al. Photodynamic therapy for cancer of the lower female genital tract. Coloscop Gynecol Laser Surg 1985, 2: 185-8.
93. McCaughan, J.S., Guy, J.T., Hicks, W. et al. Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. Arch Surg 1989, 24: 211-6.
94. Spérduto, P.W., DeLaney, T.F., Thomas, G. et al. Photodynamic therapy for chest wall recurrence in breast cancer. Int J Radiat Oncol Biol Phys 1991, 21: 441-6.
95. Barr, H., Bown, S.G., Krasner, N., Boulos, P.B. Photodynamic therapy for colorectal disease. Int J Colorect Dis 1989, 4: 15-9.
96. Herrera-Ornelas, L., Petrelli, N.J., Mittelman, A. et al. Photodynamic therapy in patients with colorectal cancer. Cancer 1986, 57: 677-84.
97. Hochain, P., Duvcrotté, B., Paillot, Y-T. et al. Photodynamic therapy for small esophageal squamous cell carcinomas: An alternative? Gastroenterol Clin Biol 1992, 16: 552-7.
98. Kato, H., Kawaguchi, M., Konaka, C. et al. Evaluation of photodynamic therapy in gastric cancer. Lasers Med Sci 1986, 1: 67-74.
99. McCaughan, J.D., Nims, T.A., Guy, J.T. et al. Photodynamic therapy for esophageal tumors. Arch Surg 1989, 124: 74-80.
100. DeLaney, T.F., Sindelar, W.F., Tochner, Z. et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int J Radiat Oncol Biol Phys 1993, 25: 445-57.
101. Nambisan, R.N. Karakousis, C.P., Holyoke, E.D. et al. Intraoperative photodynamic therapy for retroperitoneal sarcoma. Cancer 1988, 61: 1248-15.
102. Chatlani, P.T., Nuutinen, P.J.O., Noda, N. et al. Selective necrosis in hamster pancreatic tumours using photodynamic therapy with phthalocyanine photosensitization. Brit J Surg 1992, 79: 786-90.
103. 1Keller, S.E., Hajri, A., Balboni, G. et al. Experimental pancreatic cancer in the rat treated by photodynamic therapy. Brit J Surg 1994, 81: 1185-9.
104. Mang, T.S., Wieman, T.J. Photodynamic therapy in the treatment of pancreatic carcinoma: Dihematoporphyrin ether uptake and photobleaching kinetics. Photochem Photobiol 1987, 46: 853-8.
105. Regula, J., Ravi, B., Bedwell, J. et al. Photodynamic therapy using 5-aminolevulinic acid for experimental pancreatic cancer - Prolonged animal survival. Brit J Cancer 1994, 70: 248-54.
106. Wilson, B.C., Jeeves, W.P., Lowe, D.M. In vivo and post mortem measurements of the attenuation spectra of light in mammalian tissues. Photochem Photobiol 1985, 42: 153-62.
107. Svaasand, L.O., Ellingsen, R. Optical penetration in human intracranial tumors. Photochem Photobiol 1985, 41: 73-6.
108. Gluckman, J.L. Hematoporphyrin derivative photodynamic therapy: Is there truly a future in head and neck oncology? Reflections on a 5-year experience. Laryngoscope 1991, 191: 636-42.
109. Schuller, D.E., McCaughan, J.S., Rock, R.P. Photodynamic therapy in head and neck cancer. Arch Otolaryngol 1985, 111: 351-5.
110. Wile, A.G., Novotny, J., Mason, G.R. et al. Photoradiation therapy of head and neck cancer. Amer J Clin Oncol 1984, 6: 39-43.
111. Feyh, J. The treatment of larynx papillomas with the aid of photodynamic therapy. In: Photodynamic Therapy and Biomedical Lasers. Spinelli, P., DalFante, M., Marchese, R. (Eds.). Elsevier Science: New York 1992, 653-5.
112. Shikowitz, M.J., Steinberg, B.M., Abramson, A. Hematoporphyrin derivative therapy of papillomas: Experimental study. Arch Otolaryngol Head Neck Surg 1986, 112: 42-6.
113. Basheda, S.G., Mehta, A.C., De Boer, G. et al. Endobronchial and parenchymal juvenile laryngotracheobronchial papillomatosis. Effects of photodynamic therapy. Chest 1991, 100: 1458-61.
114. Biel, M. Photodynamic therapy and the treatment of neoplastic and non-neoplastic diseases of the larynx. In: Photodynamic Therapy and Biomedical Lasers. Spinelli, P., DalFante, M., Marchese, R. (Eds.). Elsevier Science: New York 1992, 647-52.
115. Biel, M. Photodynamic therapy and the treatment of neoplastic diseases of the larynx, oral cavity, pharynx and tracheobronchial tree. Proc SPIE 1993, 1881, 10-9.
116. Biel, M. Photodynamic therapy and treatment of neoplastic diseases of the larynx. Laryngoscope 1994, 104: 388-403.